This article explores how new approach methodologies are transforming drug discovery through human-relevant models, including ...

With PAT, pharmaceutical manufacturers achieve real-time process control, enhancing drug quality and accelerating the ...

Through predictive modelling, AI supports target identification, prediction of physicochemical properties and formulation strategy selection.

Anthropic also went a step further, saying it would develop drugs of its own. Head of life sciences Eric Kauderer-Abrams said ...

Anthropic announced the creation of its new Claude Science tool, which aims to help scientists speed up the drug development ...

Phase 1 Study Designed to Evaluate the Safety, Tolerability and Pharmacokinetics of AT-587 in Healthy Volunteers ...

Few places on the planet have more at stake in AI’s transformation and disruption of life sciences than the Massachusetts ...

AI is transforming medicine development by accelerating drug discovery and clinical trials, reducing costs, and enhancing the ...

Healthcare veteran Dr Douglas Williams discusses the impact of recent political upheaval in the US and the prospect of major ...

Incubated by Houston-based Fannin Innovation Studio, the 11h drug created in Nebraska will move toward phase 1 clinical ...

An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...

Today, the integration of AI and digital technologies is fundamentally rewriting the rules of R&D—serving as the ultimate breakthrough to shatter industry bottlenecks and drive unprecedented ...